| Year |
Citation |
Score |
| 2024 |
Nezir AE, Bolat ZB, Saka OM, Zemheri IE, Gülyüz S, Özköse UU, Yilmaz Ö, Bozkir A, Şahin F, Telci D. PEtOx-DOPE nanoliposomes functionalized with peptide 563 in targeted delivery to prostate cancer. Turkish Journal of Biology = Turk Biyoloji Dergisi. 48: 174-181. PMID 39050711 DOI: 10.55730/1300-0152.2693 |
0.746 |
|
| 2023 |
Gülyüz S, Sessevmez M, Ukuser G, Khalily MP, Tiryaki S, Sipahioglu T, Birgül K, Ömeroğlu İ, Özçubukçu S, Telci D, Küçükgüzel ŞG, Durmuş M, Cevher E, Yılmaz Ö. A Novel PEtOx-Based Nanogel Targeting Prostate Cancer Cells for Drug Delivery. Macromolecular Bioscience. e2300324. PMID 37827519 DOI: 10.1002/mabi.202300324 |
0.774 |
|
| 2023 |
Nezir AE, Bolat ZB, Ozturk N, Kocak P, Zemheri E, Gulyuz S, Ozkose UU, Yilmaz O, Vural I, Bozkır A, Sahin F, Telci D. Targeting prostate cancer with docetaxel-loaded peptide 563-conjugated PEtOx-co-PEI-b-PCL polymeric micelle nanocarriers. Amino Acids. PMID 37318626 DOI: 10.1007/s00726-023-03292-3 |
0.759 |
|
| 2021 |
Bolat ZB, Nezir AE, Devrim B, Zemheri E, Gulyuz S, Ozkose UU, Yilmaz O, Bozkir A, Telci D, Sahin F. Delivery of doxorubicin loaded P18 conjugated-poly(2-ethyl-oxazoline)-DOPE nanoliposomes for targeted therapy of breast cancer. Toxicology and Applied Pharmacology. 428: 115671. PMID 34391753 DOI: 10.1016/j.taap.2021.115671 |
0.736 |
|
| 2021 |
Özkan İ, Koçak P, Yıldırım M, Ünsal N, Yılmaz H, Telci D, Şahin F. Garlic (Allium sativum)-derived SEVs inhibit cancer cell proliferation and induce caspase mediated apoptosis. Scientific Reports. 11: 14773. PMID 34285262 DOI: 10.1038/s41598-021-93876-4 |
0.362 |
|
| 2021 |
Devrim B, Bolat ZB, Telci D, Şahin F, Gulyuz S, Ozkose UU, Yilmaz O, Bozkır A. Design and evaluation of peptide-18-targeted nanoliposomes constructed by poly(2-oxazoline)-DOPE for doxorubicin delivery. Journal of Microencapsulation. 1-13. PMID 33853478 DOI: 10.1080/02652048.2021.1905094 |
0.342 |
|
| 2021 |
Nezir AE, Khalily MP, Gulyuz S, Ozcubukcu S, Küçükgüzel ŞG, Yilmaz O, Telci D. Synthesis and evaluation of tumor-homing peptides for targeting prostate cancer. Amino Acids. PMID 33846842 DOI: 10.1007/s00726-021-02971-3 |
0.759 |
|
| 2021 |
Oz UC, Bolat ZB, Ozkose UU, Gulyuz S, Kucukturkmen B, Khalily MP, Ozcubukcu S, Yilmaz O, Telci D, Esendagli G, Sahin F, Bozkir A. A robust optimization approach for the breast cancer targeted design of PEtOx-b-PLA polymersomes. Materials Science & Engineering. C, Materials For Biological Applications. 123: 111929. PMID 33812571 DOI: 10.1016/j.msec.2021.111929 |
0.355 |
|
| 2021 |
Rencuzogulları O, Yerlikaya PO, Gürkan AÇ, Arısan ED, Telci D. Palbociclib negatively regulates fatty acid synthesis due to upregulation of AMPKα and miR-33a levels to increase apoptosis in Panc-1 and MiaPaCa-2 cells. Biotechnology and Applied Biochemistry. PMID 33538066 DOI: 10.1002/bab.2113 |
0.608 |
|
| 2020 |
Kocak P, Oz UC, Bolat ZB, Ozkose UU, Gulyuz S, Tasdelen MA, Yilmaz O, Bozkir A, Sahin F, Telci D. The Utilization of Poly(2-ethyl-2-oxazoline)-b-Poly(ε-caprolactone) Ellipsoidal Particles for Intracellular BIKDDA Delivery to Prostate Cancer. Macromolecular Bioscience. e2000287. PMID 33191572 DOI: 10.1002/mabi.202000287 |
0.446 |
|
| 2020 |
Erkan H, Telci D, Dilek O. Design of Fluorescent Probes for Bioorthogonal Labeling of Carbonylation in Live Cells. Scientific Reports. 10: 7668. PMID 32376913 DOI: 10.1038/S41598-020-64790-Y |
0.355 |
|
| 2020 |
Ozturk K, Selen Onal M, Efiloglu O, Nikerel E, Yildirim A, Telci D. Association of 5'UTR polymorphism of secretory Phospholipase A2 group IIA (PLA2G2A) gene with Prostate Cancer Metastasis. Gene. 144589. PMID 32179174 DOI: 10.1016/J.Gene.2020.144589 |
0.648 |
|
| 2020 |
Gulyuz S, Bayram D, Ozkose UU, Bolat ZB, Kocak P, Saka OM, Devrim B, Khalily MP, Telci D, Sahin F, Özçubukçu S, Sezer E, Tasdelen MA, Alpturk O, Bozkır A, et al. Synthesis, biocompatibility and gene encapsulation of poly(2-Ethyl 2-Oxazoline)-dioleoyl phosphatidylethanolamine (PEtOx-DOPE) and post-modifications with peptides and fluorescent dye coumarin International Journal of Polymeric Materials. 1-13. DOI: 10.1080/00914037.2020.1767617 |
0.36 |
|
| 2020 |
Oz UC, Bolat ZB, Poma A, Guan L, Telci D, Sahin F, Battaglia G, Bozkır A. Correction to: Prostate cancer cell-specific BikDDA delivery by targeted polymersomes Applied Nanoscience. 10: 3403-3404. DOI: 10.1007/S13204-020-01457-0 |
0.543 |
|
| 2020 |
Oz UC, Bolat ZB, Poma A, Guan L, Telci D, Sahin F, Battaglia G, Bozkır A. Prostate cancer cell-specific BikDDA delivery by targeted polymersomes Applied Nanoscience. 10: 3389-3401. DOI: 10.1007/S13204-020-01287-0 |
0.578 |
|
| 2019 |
Rencuzogulları O, Yerlikaya PO, Gürkan AÇ, Arısan ED, Telci D. Palbociclib, a selective CDK4/6 inhibitor, restricts cell survival and epithelial-mesenchymal transition in Panc-1 and MiaPaCa-2 pancreatic cancer cells. Journal of Cellular Biochemistry. PMID 31264276 DOI: 10.1002/Jcb.29249 |
0.635 |
|
| 2019 |
Nayman AH, Siginc H, Zemheri E, Yencilek F, Yildirim A, Telci D. Dual-Inhibition of mTOR and Bcl-2 Enhances the Anti-tumor Effect of Everolimus against Renal Cell Carcinoma and . Journal of Cancer. 10: 1466-1478. PMID 31031856 DOI: 10.7150/Jca.29192 |
0.412 |
|
| 2019 |
Nezir AE, Ulukan B, Telci D. Transglutaminase 2: The Maestro of the Oncogenic Mediators in Renal Cell Carcinoma. Medical Sciences (Basel, Switzerland). 7. PMID 30736384 DOI: 10.3390/Medsci7020024 |
0.704 |
|
| 2017 |
Doğan A, Demirci S, Telci D, Canikyan S, Kongur M, Dede B, Şahin F. Anticancer activity of Schiff base-Poloxamer P85 combination against kidney cancer. International Urology and Nephrology. PMID 29288416 DOI: 10.1007/S11255-017-1782-9 |
0.405 |
|
| 2017 |
Demirci S, Doğan A, Başak Türkmen N, Telci D, Çağlayan AB, Beker MÇ, Kiliç E, Özkan F, Dede B, Şahin F. Poloxamer P85 increases anticancer activity of Schiff base against prostate cancer in vitro and in vivo. Anti-Cancer Drugs. PMID 28614092 DOI: 10.1097/Cad.0000000000000528 |
0.544 |
|
| 2017 |
Bagatur Y, Ilter Akulke AZ, Bihorac A, Erdem M, Telci D. Tissue transglutaminase expression is necessary for adhesion, metastatic potential and cancer stemness of renal cell carcinoma. Cell Adhesion & Migration. 1-14. PMID 28498731 DOI: 10.1080/19336918.2017.1322255 |
0.433 |
|
| 2016 |
Demirci S, Doğan A, Türkmen NB, Telci D, Rizvanov AA, Şahin F. Schiff base-Poloxamer P85 combination demonstrates chemotherapeutic effect on prostate cancer cells in vitro. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 86: 492-501. PMID 28012929 DOI: 10.1016/J.Biopha.2016.11.101 |
0.545 |
|
| 2016 |
Doğan A, Demirci S, Türkmen NB, Çağlayan AB, Aydın S, Telci D, Kılıç E, Şahin K, Orhan C, Tuzcu M, Ekici AI, Şahin F. Schiff base-poloxamer P85 combination prevents prostate cancer progression in C57/Bl6 mice. The Prostate. PMID 27338565 DOI: 10.1002/Pros.23229 |
0.502 |
|
| 2015 |
Demirci S, Doğan A, Başak N, Telci D, Dede B, Orhan C, Tuzcu M, Şahin K, Şahin N, Özercan İH, Şahin F. A Schiff base derivative for effective treatment of diethylnitrosamine-induced liver cancer in vivo. Anti-Cancer Drugs. 26: 555-64. PMID 25714251 DOI: 10.1097/Cad.0000000000000221 |
0.352 |
|
| 2015 |
Erdem S, Yegen G, Telci D, Yildiz I, Tefik T, Issever H, Kilicaslan I, Sanli O. The increased transglutaminase 2 expression levels during initial tumorigenesis predict increased risk of metastasis and decreased disease-free and cancer-specific survivals in renal cell carcinoma. World Journal of Urology. 33: 1553-60. PMID 25515319 DOI: 10.1007/S00345-014-1462-7 |
0.368 |
|
| 2014 |
Erdem M, Erdem S, Sanli O, Sak H, Kilicaslan I, Sahin F, Telci D. Up-regulation of TGM2 with ITGB1 and SDC4 is important in the development and metastasis of renal cell carcinoma. Urologic Oncology. 32: 25.e13-20. PMID 23499501 DOI: 10.1016/J.Urolonc.2012.08.022 |
0.319 |
|
| 2013 |
Aysan E, Bayrak OF, Aydemir E, Telci D, Sahin F, Yardimci C, Muslumanoglu M. Cancer preventive effects of whole cell type immunization against mice Ehrlich tumors. Asian Pacific Journal of Cancer Prevention : Apjcp. 14: 3515-9. PMID 23886138 DOI: 10.7314/Apjcp.2013.14.6.3515 |
0.314 |
|
| 2012 |
Sarıca K, Aydin H, Yencilek F, Telci D, Yilmaz B. Human umbilical vein endothelial cells accelerate oxalate-induced apoptosis of human renal proximal tubule epithelial cells in co-culture system which is prevented by pyrrolidine dithiocarbamate. Urological Research. 40: 461-6. PMID 22223028 DOI: 10.1007/S00240-011-0450-2 |
0.321 |
|
| 2010 |
Wang Z, Telci D, Griffin M. Importance of syndecan-4 and syndecan -2 in osteoblast cell adhesion and survival mediated by a tissue transglutaminase-fibronectin complex. Experimental Cell Research. 317: 367-81. PMID 21036168 DOI: 10.1016/J.Yexcr.2010.10.015 |
0.381 |
|
| 2010 |
Wang Z, Collighan RJ, Gross SR, Danen EH, Orend G, Telci D, Griffin M. RGD-independent cell adhesion via a tissue transglutaminase-fibronectin matrix promotes fibronectin fibril deposition and requires syndecan-4/2 α5β1 integrin co-signaling. The Journal of Biological Chemistry. 285: 40212-29. PMID 20929862 DOI: 10.1074/Jbc.M110.123703 |
0.342 |
|
| 2010 |
Arisan ED, Kutuk O, Tezil T, Bodur C, Telci D, Basaga H. Small inhibitor of Bcl-2, HA14-1, selectively enhanced the apoptotic effect of cisplatin by modulating Bcl-2 family members in MDA-MB-231 breast cancer cells. Breast Cancer Research and Treatment. 119: 271-81. PMID 19238538 DOI: 10.1007/S10549-009-0343-Z |
0.652 |
|
| 2008 |
Telci D, Wang Z, Li X, Verderio EA, Humphries MJ, Baccarini M, Basaga H, Griffin M. Fibronectin-tissue transglutaminase matrix rescues RGD-impaired cell adhesion through syndecan-4 and beta1 integrin co-signaling. The Journal of Biological Chemistry. 283: 20937-47. PMID 18499669 DOI: 10.1074/Jbc.M801763200 |
0.324 |
|
| 2003 |
Verderio EA, Telci D, Okoye A, Melino G, Griffin M. A novel RGD-independent cel adhesion pathway mediated by fibronectin-bound tissue transglutaminase rescues cells from anoikis. The Journal of Biological Chemistry. 278: 42604-14. PMID 12732629 DOI: 10.1074/Jbc.M303303200 |
0.357 |
|
| Show low-probability matches. |